证券代码：300107 证券简称：建新股份 公告编号：2023-049 河北建新化工股份有限公司 关于 2022 年股票期权与限制性股票激励计划 之股票期权第一个行权期采用自主行权的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、公司 2022 年股票期权与限制性股票激励计划股票期权代码：036503，期 权简称：建新 JLC3。 2、本次符合行权条件的 74 名激励对象在第一个行权期可行权 332.72 万份 股票期权，行权价格为 5.39 元/份。 3、本次行权拟采用自主行权模式，实际可行权期限为 2023 年 9 月 14 日至 2024 年 7 月 10 日。 4、本次可行权期权若全部行权，公司股份仍具备上市条件。 河北建新化工股份有限公司（以下简称"公司"）于 2023 年 7 月 11 日召开 的第六届董事会第二次会议、第六届监事会第二次会议，审议通过了《关于 2022 年股票期权与限制性股票激励计划之股票期权第一个行权期行权条件成就的议 案》。根据 2022 年第一次临时股东大会的相关授权，公司董事会将按照相关规 定办 ...

证券代码：300107 证券简称：建新股份 公告编号：2023-048 河北建新化工股份有限公司 2022 年股票期权与限制性股票激励计划之限制性股票第一个归 属期归属结果暨股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 1、本次归属股票数量：403.75 万股，占归属前公司总股本的比例为 0.73%。 2、本次归属股票上市流通时间：2023 年 9 月 14 日。 4、授予数量（调整前）：公司向激励对象授予 819.50 万股限制性股票 3、本次限制性股票归属条件的激励对象共计 23 人。 4、本次限制性股票归属股票来源：公司向激励对象定向发行公司 A 股普通 股。 河北建新化工股份有限公司（以下简称"公司"）于 2023 年 7 月 11 日召开第 六届董事会第二次会议、第六届监事会第二次会议，审议通过了《关于 2022 年 股票期权与限制性股票激励计划之限制性股票第一个归属期归属条件成就的议 案》。近日，公司办理了 2022 年股票期权与限制性股票激励计划之限制性票第 一个归属期归属股份的登记工作，现将相关事项公 ...

Financial Performance - The company's operating revenue for the first half of 2023 was ¥280,588,419.32, a decrease of 25.81% compared to ¥378,201,946.89 in the same period last year[22]. - The net profit attributable to shareholders of the listed company was ¥8,266,463.85, down 76.59% from ¥35,305,761.32 in the previous year[22]. - The net profit after deducting non-recurring gains and losses was ¥6,231,636.07, representing an 81.59% decrease from ¥33,849,539.65 in the same period last year[22]. - The net cash flow from operating activities was ¥17,752,153.65, a decline of 76.19% compared to ¥74,547,016.06 in the previous year[22]. - Basic earnings per share were ¥0.0150, down 76.56% from ¥0.0640 in the same period last year[22]. - The total profit for the period was 9.69 million yuan, down 75.69% year-on-year[34]. - The company reported a significant increase in trading financial assets to ¥30,540,000.00, up from ¥20,000,492.46, representing 1.89% of total assets[47]. - The total revenue for the first half of 2023 was 85 million RMB, representing a 67% increase compared to the same period last year[59]. - The net profit for the first half of 2023 reached 3 million RMB, with a significant increase of 140% year-on-year[59]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,614,877,774.07, a decrease of 3.13% from ¥1,667,011,929.77 at the end of the previous year[22]. - The net assets attributable to shareholders of the listed company were ¥1,444,789,443.52, down 1.08% from ¥1,460,586,134.15 at the end of the previous year[22]. - Cash and cash equivalents decreased to ¥440,926,031.43, accounting for 27.30% of total assets, down from 30.18%[47]. - Accounts receivable dropped to ¥70,357,505.75, representing 4.36% of total assets, down from 6.01%[47]. - Inventory increased to ¥149,012,253.28, now 9.23% of total assets, up from 6.89%[47]. - Fixed assets rose to ¥519,684,356.22, making up 32.18% of total assets, an increase from 29.92%[47]. - Total liabilities decreased to CNY 170,088,330.55 from CNY 206,445,439.61, a reduction of approximately 17.6%[138]. Business Operations - The main business includes the production and sales of benzene-based intermediates, with applications in pharmaceuticals, agrochemicals, dyes, and paper chemicals[30]. - The company has established long-term stable partnerships with global chemical giants, with products sold in over 20 countries and regions[33]. - The company is focusing on optimizing the industrial chain structure and aims to enhance product value through technological advancements[33]. - The company is implementing a strategy of "horizontal expansion and vertical elongation" to drive long-term growth[33]. - The company is leveraging new technologies such as industrial IoT to enhance operational efficiency and product quality[34]. - The company has a complete direct sales system and a stable sales and after-sales service team to ensure customer satisfaction[31]. - The company plans to expand its product offerings in the chemical sector, focusing on new technologies and market segments[51]. - The company is actively involved in the research and development of new products and technologies to enhance its market competitiveness[54]. Investment and Financial Strategy - The company did not engage in any fundraising activities during the reporting period, maintaining a conservative financial strategy[55]. - The company has not reported any significant non-equity investments during the reporting period, reflecting a cautious investment approach[56]. - The company is exploring potential mergers and acquisitions to expand its market presence and product offerings[54]. - The company plans to increase its investment in its wholly-owned subsidiary, Cangzhou Jianxin Ruixiang Chemical Technology Co., Ltd., by RMB 100 million, raising its registered capital from RMB 150 million to RMB 250 million[66]. - The company has made strategic investments in new projects, including a capital increase in a subsidiary focused on chemical production[51]. Environmental and Social Responsibility - The company has developed a complete set of wastewater treatment facilities that achieve 80% resource reuse of industrial wastewater, ensuring sustainable development[41]. - The company is committed to increasing its environmental protection investments to comply with stricter regulations in the fine chemical industry[70]. - The company has implemented a self-monitoring plan for environmental emissions, which includes monitoring various pollutants and their discharge limits[87]. - The company emphasizes social responsibility by integrating it into shareholder and employee rights protection, as well as environmental protection[89]. - The company actively participates in community development through public welfare initiatives, including water supply improvements and public lighting installations[91]. Risk Management - The management has highlighted risks related to macro policies and market conditions that may impact future performance[5]. - The company faces macro policy risks but believes its product development strategy aligns with national industrial policy, minimizing such risks[68]. - The company is exposed to market risks due to rising overseas energy prices and high inflation, which may adversely affect its export business[68]. - The company emphasizes the importance of attracting and retaining high-quality technical and management talent to mitigate risks associated with talent shortages[69]. - The company exports a significant portion of its products, making it vulnerable to exchange rate fluctuations, particularly against the US dollar[69]. Shareholder Information - The company did not distribute cash dividends or bonus shares for the half-year period[77]. - The company approved the stock option and restricted stock incentive plan on July 1, 2022, granting 7.258 million stock options to 78 incentive recipients and 8.195 million restricted shares to 23 recipients[79]. - The largest shareholder, Zhu Shouchan, holds 39.11% of the total shares, amounting to 215,768,643 shares, with 161,826,482 being restricted[124]. - The total number of shareholders at the end of the reporting period was 25,232[123]. - The company has a policy that limits the transfer of shares by directors and senior management to no more than 25% of their total holdings each year[118]. Compliance and Governance - The semi-annual financial report for 2023 has not been audited[97]. - The company has adhered to all commitments made regarding equity incentives and related party transactions[1][2]. - The company has not engaged in any asset or equity acquisitions or sales during the reporting period[100]. - The company has not reported any entrusted loans in the current reporting period[61]. - The company has established comprehensive safety production regulations to mitigate risks associated with the use of flammable and explosive chemicals[71].

证券代码：300107 证券简称：建新股份 公告编号：2023-043 董 事 会 二〇二三年八月十七日 第六届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下简称"公司"）第六届董事会第三次会议 于2023年8月17日在公司会议室以现场结合通讯方式召开。会议通知于2023年8 月7日以书面及通讯的方式发出，本次会议应出席董事9人，实际出席董事9人， 会议由公司董事长朱守琛先生主持。公司全体监事、部分高级管理人员列席了会 议。会议的召集、召开、表决程序符合《中华人民共和国公司法》和《公司章程》 的规定。会议经全体董事表决，通过以下事项： 审议通过了《关于<2023年半年度报告>及其摘要的议案》 董事会认为，《2023年半年度报告》及其摘要的内容能够真实、准确、完整 地反映公司经营情况，不存在虚假记载、误导性陈述或重大遗漏。 公司《2023年半年度报告》及其摘要，详见同日披露于中国证监会指定的创 业板上市公司信息披露网站巨潮资讯网(www.cninfo.com.cn)的公告。 本议案以同意9票，反对0票，弃 ...

河北建新化工股份有限公司独立董事 关于第六届董事会第三次会议相关事项的独立意见 根据《关于在上市公司建立独立董事制度的指导意见》、《深圳证券交易所 创业板股票上市规则》、《深圳证券交易所上市公司自律监管指引第 2 号——创 业板上市公司规范运作》、河北建新化工股份有限公司（以下简称"公司"）《独 立董事工作细则》和《公司章程》的有关规定，我们作为公司的独立董事，对公 司第六届董事会第三次会议相关事项进行了认真审议，并发表如下独立意见： 关于控股股东及其他关联方占用公司资金、公司对外担保情况的独立意见 根据《上市公司监管指引第 8 号——上市公司资金往来、对外担保的监管要 求》（证监会公告〔2022〕26 号）、《深圳证券交易所创业板上市公司自律监 管指南第 1 号——业务办理》等相关文件规定,我们对 2023 年半年度公司控股股 东及关联方占用公司资金和对外担保情况进行了认真核查,发表独立意见如下: 李胜楠 张先中 张兰丁 （此页无正文，为《河北建新化工股份有限公司独立董事关于第六届董事 会第三次会议相关事项的独立意见》之签字页） 1、报告期内，公司不存在控股股东、实际控制人及其他关联方占用公司资 金的情况。 ...

公司《2023 年半年度报告》及其摘要，详见同日披露于中国证监会指定的 创业板上市公司信息披露网站巨潮资讯网(www.cninfo.com.cn)的公告。 证券代码：300107 证券简称：建新股份 公告编号：2023-044 河北建新化工股份有限公司 第六届监事会第三次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下简称"公司"）第六届监事会第三次会议 于2023年8月17日在公司会议室以现场方式召开。会议通知于2023年8月7日以书 面及通讯的方式发出，本次会议应出席监事3人，实际出席监事3人，会议由公司 监事会主席孙维政先生主持。公司部分董事、高级管理人员列席了会议。会议召 集、召开、表决程序符合《中华人民共和国公司法》和《公司章程》的规定。会 议经全体监事表决，通过以下事项： 审议通过了《关于<2023 年半年度报告>及其摘要的议案》 经审核，监事会认为董事会编制和审核河北建新化工股份有限公司《2023 年半年度报告》及其摘要的程序符合法律、行政法规和中国证监会的规定，报告 内容真实、准确、完整的反映了上市公 ...

河北建新化工股份有限公司 | 非经营性资金占用 | | 资金占用 | 占用方与上市公司 | 上市公司核 | 2023 年初占用 | 2023 年半年度占用 累计发生金额（不 | 2023 年半年度 占用资金的利息 | 2023 年半年度 偿还累计发生 | 2023 年半年 末占用资金 | 占用形成原 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 方名称 | 的关联关系 | 算的会计科目 | 资金余额 | 含利息） | （如有） | 额 | 余额 | 因 | | | 控股股东、实际控制人及其 | | | | | | | | | | | 非经营性占用 | | 附属企业 | | | | | | | | | | | 非经营性占用 | | 小 | 计 | —— | —— | —— | | | | | | —— | —— | | 前控股股东、实际控制人及 | | | | | | | | | | | 非经营性占用 | | 其附属企业 | | | | | | | | | | | 非经营性占用 | ...

Group 1: Event Details - Hebei Jianxin Chemical Co., Ltd. will participate in the "2023 Hebei Listed Companies Investor Collective Reception Day" [1] - The event will be held online on May 30, 2023, from 15:00 to 17:00 [1] - Investors can join via the "Panorama Roadshow" website, WeChat official account, or Panorama Roadshow APP [1] Group 2: Communication Topics - Company executives will discuss the 2022 annual performance, corporate governance, development strategy, operational status, financing plans, equity incentives, and sustainable development [1] - The event aims to enhance interaction and communication with investors [1] Group 3: Assurance of Information - The company and its board guarantee the authenticity, accuracy, and completeness of the disclosed information, with no false records or misleading statements [1]

Financial Performance - The company's operating revenue for Q1 2023 was ¥126,497,669.98, a decrease of 23.28% compared to ¥164,880,447.49 in the same period last year[5] - Net profit attributable to shareholders was ¥3,613,439.28, down 66.76% from ¥10,869,146.47 year-on-year[5] - The total profit for Q1 2023 was ¥3,483,848.75, a decrease of 71.35% compared to ¥12,158,781.45 in the same period last year[9] - The basic earnings per share dropped to ¥0.0065, a decline of 67.01% from ¥0.0197 in the same period last year[5] - Total operating costs for Q1 2023 were CNY 125,409,896.56, down 17.3% from CNY 151,544,489.54 in the same period last year[21] Cash Flow - The net cash flow from operating activities decreased by 71.11% to ¥9,917,607.93, compared to ¥34,330,538.40 in the previous year[11] - Total cash inflow from operating activities is ¥110,587,295.41, down from ¥113,204,651.47, reflecting a decline of approximately 2.3%[26] - Cash outflow from operating activities increased to ¥100,669,687.48, compared to ¥78,874,113.07 in the previous period, marking an increase of about 27.6%[26] - The net increase in cash and cash equivalents for the current period is -¥19,743,992.77, compared to an increase of ¥21,220,294.71 in the previous period[26] - The ending balance of cash and cash equivalents is ¥333,316,261.82, down from ¥414,299,478.43, reflecting a decrease of approximately 19.6%[26] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥1,651,648,234.68, a slight decrease of 0.92% from ¥1,667,011,929.77 at the end of the previous year[5] - Total current assets decreased to CNY 842,547,810.84 from CNY 857,735,689.79, a decline of 1.8%[20] - Total liabilities decreased to CNY 184,518,870.18 from CNY 206,445,439.61, a reduction of 10.6%[20] - Accounts receivable decreased to ¥74,262,822.73 from ¥100,196,451.93, indicating a decline of about 26%[18] Research and Development - Research and development expenses increased by 30.83% to ¥6,533,821.95, compared to ¥4,994,296.90 in Q1 2022[9] - The company plans to continue focusing on R&D and cost management strategies to improve profitability in the upcoming quarters[22] Shareholder Information - The total number of common shareholders at the end of the reporting period is 26,539[13] - The largest shareholder, Zhu Shouchan, holds 39.11% of the shares, totaling 215,768,643 shares[13] - The company has a total of 214,222,986 restricted shares at the end of the period, with 13,783 shares released during the quarter[16] - The number of shares held by the top ten unrestricted shareholders includes Zhu Shouchan with 53,942,161 shares[13] - The company maintains a focus on strategic shareholder relationships, with several major shareholders being family members of the largest shareholder[13] Other Income and Expenses - The company reported a significant increase in other income, which rose by 561.76% to ¥2,104,372.91 due to increased government subsidies[9] - The company experienced a 64.88% decrease in investment income, which fell to ¥139,319.53 from ¥396,676.84 in the previous year[9] - The company paid ¥23,258,629.99 in cash to employees, an increase from ¥21,159,682.39 in the previous period, representing an increase of about 9.9%[26] Investment Activities - Cash flow from investment activities shows a net outflow of ¥29,008,163.17, worsening from a net outflow of ¥12,500,596.21 in the previous period[26] - Cash inflow from investment activities decreased significantly to ¥20,501,834.33 from ¥73,692,500.17, a drop of approximately 72%[26] - Cash outflow from investment activities was ¥49,509,997.50, down from ¥86,193,096.38, indicating a reduction of about 42.5%[26] Mergers and Acquisitions - The company has not disclosed any new product or technology developments in the current report[14] - There are no significant mergers or acquisitions reported in the current quarter[14]

Financial Performance - The company's operating revenue for 2022 was ¥742,465,457.59, representing an increase of 18.20% compared to ¥628,149,906.61 in 2021[25]. - The net profit attributable to shareholders in 2022 was ¥61,274,503.04, a significant increase of 349.12% from ¥13,643,293.97 in 2021[25]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥52,741,320.76, up 909.87% from ¥5,222,597.50 in 2021[25]. - The basic earnings per share for 2022 was ¥0.1111, an increase of 349.80% compared to ¥0.0247 in 2021[25]. - The total assets at the end of 2022 were ¥1,667,011,929.77, reflecting a growth of 4.79% from ¥1,590,772,108.66 at the end of 2021[25]. - The net assets attributable to shareholders at the end of 2022 were ¥1,460,586,134.15, a slight increase of 1.24% from ¥1,442,694,269.98 at the end of 2021[25]. - The net cash flow from operating activities in 2022 was ¥163,360,835.84, a decrease of 14.79% from ¥191,719,039.31 in 2021[25]. - The company reported a weighted average return on equity of 4.23% in 2022, up from 0.94% in 2021[25]. - The total profit reached 64.22 million yuan, representing a significant growth of 434.56% year-on-year[46]. - The revenue from the fine chemical industry was ¥740,699,243.80, accounting for 99.76% of total revenue, with a year-on-year growth of 18.96%[54]. Dividend Distribution - The company plans to distribute a cash dividend of 0.6 RMB per 10 shares to all shareholders, based on a total of 551,731,068 shares[7]. - A cash dividend of CNY 0.60 per 10 shares (including tax) was proposed, totaling CNY 33,103,864.08, which represents 100% of the profit distribution amount[132]. - The total number of shares for the dividend distribution is 551,731,068, with no stock dividends or capital reserve transfers proposed[132]. Market and Competitive Position - The company aims to enhance R&D investment and optimize product structure to improve market competitiveness and safeguard profitability[3]. - The company will continue to focus on expanding both domestic and international markets to enhance its business presence and customer base[3]. - The company is focused on optimizing its industrial chain structure with a strategy of "expanding horizontally and strengthening vertically" to enhance market competitiveness[36]. - The company has developed a unique "one chain three bodies" product structure, focusing on intermediates for various industries, including pharmaceuticals and agriculture[42]. - The company is actively engaged in research and development of new products and technologies, aiming to improve overall production levels and promote clean production processes[36]. Risks and Challenges - The company faces market risks from rising overseas energy prices and high inflation, which may negatively impact export business and sales volume[3]. - The company acknowledges a risk of talent shortages in technical and management areas, which may hinder future development[5]. - The company is exposed to exchange rate risks due to a significant portion of exports being settled in USD, and it plans to monitor foreign exchange trends closely[5]. - The company emphasizes a low macro policy risk due to alignment with national industrial policy adjustments, allowing for strategic development adjustments as needed[3]. Environmental and Safety Compliance - The company is committed to increasing environmental investment to meet stricter regulatory standards and improve overall environmental awareness[6]. - The company has established comprehensive safety production regulations to mitigate risks associated with the use of flammable and explosive chemicals[7]. - The company has implemented a comprehensive environmental monitoring plan, approved by local authorities, to ensure compliance with pollution discharge standards[148]. - The company has established a compliance evaluation report for environmental regulations, assessing adherence to legal requirements annually[144]. - The company has not reported any significant environmental pollution incidents or violations in the past year[144]. Research and Development - The company is dedicated to improving its R&D capabilities and product competitiveness through increased management efficiency and strategic market expansion[3]. - The company's R&D investment amounted to ¥31,810,219.32 in 2022, representing 4.28% of total revenue, a slight decrease from 4.50% in 2021[68]. - The company has invested 50 million RMB in R&D for new technologies aimed at improving production efficiency[111]. - The company is exploring capital market functions to enhance its development and is considering issuing stocks or other capital operations to optimize its industrial layout[87]. Corporate Governance - The company has established a robust internal governance and human resource management system to enhance operational transparency and protect investor interests[52]. - The company maintains transparency in governance, ensuring equal rights for all shareholders and compliance with relevant laws and regulations[94]. - The internal audit system is in place to ensure compliance and effective risk management, with no significant issues reported in internal controls[97]. - The company has established a performance evaluation and incentive mechanism for senior management, linking their compensation to company performance[135]. Employee Management - The company has implemented an employee incentive plan, benefiting 87 individuals, to align personal goals with long-term corporate development[53]. - The total remuneration for directors, supervisors, and senior management during the reporting period amounted to 3.7251 million CNY[114]. - The company has established a salary management system that considers both internal fairness and external competitiveness, with a focus on high-responsibility and high-risk positions[125]. - The total number of employees at the end of the reporting period is 930, with 705 in production, 14 in sales, 135 in technical roles, 13 in finance, and 63 in administration[123]. Future Outlook - In 2023, the company plans to focus on traditional industry upgrades and leverage opportunities from "China Manufacturing 2025" and "carbon peak and carbon neutrality" initiatives[86]. - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 10% to 1.32 billion RMB[111]. - The company plans to enhance its distribution network, with an investment of 30 million RMB to improve logistics and supply chain operations[111]. - The company aims to enhance product value and achieve overall industry chain development by introducing new products related to dye intermediates, new material intermediates, and pharmaceutical intermediates[86].